Plus Therapeutics, Inc.

NasdaqCM:PSTV Stock Report

Market Cap: US$7.3m

Plus Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PSTV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Sep 24BuyUS$5,996Richard HawkinsIndividual4,000US$1.50
12 Sep 24BuyUS$8,512Richard HawkinsIndividual6,285US$1.35
11 Sep 24BuyUS$6,681Howard ClowesIndividual5,000US$1.34
11 Sep 24BuyUS$16,875Gregory PetersenIndividual12,500US$1.35
10 Sep 24BuyUS$5,204Andrew SimsIndividual4,098US$1.27
10 Sep 24BuyUS$9,839Marc HedrickIndividual8,000US$1.23
08 May 24BuyUS$8,501Robert LenkIndividual4,167US$2.04
08 May 24BuyUS$20,000Howard ClowesIndividual9,804US$2.04
08 May 24BuyUS$10,000Richard HawkinsIndividual4,902US$2.04
08 May 24BuyUS$25,000Gregory PetersenIndividual12,255US$2.04
08 May 24BuyUS$10,000Andrew SimsIndividual4,902US$2.04
08 May 24BuyUS$25,000Marc HedrickIndividual12,255US$2.04

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PSTV?
Owner TypeNumber of SharesOwnership Percentage
Institutions110,6791.88%
Individual Insiders150,1732.55%
VC/PE Firms560,9059.51%
General Public5,074,57686.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.4%.

Top Shareholders

Top 16 shareholders own 13.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.51%
Aigh Capital Management, LLC
560,905US$689.9k-1.37%0.28%
0.92%
Geode Capital Management, LLC
54,274US$66.8k16.4%no data
0.83%
Gregory Petersen
48,921US$60.2k34.3%no data
0.55%
The Vanguard Group, Inc.
32,541US$40.0k0%no data
0.5%
Robert Lenk
29,327US$36.1k0%no data
0.45%
Howard Clowes
26,497US$32.6k23.3%no data
0.35%
Marc Hedrick
20,425US$25.1k64.4%no data
0.26%
Richard Hawkins
15,188US$18.7k210%no data
0.22%
Ashton Thomas Private Wealth, LLC
12,913US$15.9k1,480%no data
0.17%
Andrew Sims
9,815US$12.1k71.7%no data
0.12%
BlackRock, Inc.
6,960US$8.6k0%no data
0.063%
Tower Research Capital Europe Limited
3,709US$4.6k-11.4%no data
0.0023%
Osaic Wealth, Inc. , Asset Management Arm
133US$163.90%no data
0.0017%
JPMorgan Chase & Co, Brokerage and Securities Investments
100US$123.30%no data
0.00081%
Bank of America Corporation, Asset Management Arm
48US$58.72.13%no data
0.00002%
Group One Trading LP, Asset Management Arm
1US$1.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 10:58
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Plus Therapeutics, Inc. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Andrew D'SilvaB. Riley Securities, Inc.
John SavinEdison Investment Research